These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1248 related articles for article (PubMed ID: 24122735)

  • 21. Choroid plexus tumors; management, outcome, and association with the Li-Fraumeni syndrome: the Children's Hospital Los Angeles (CHLA) experience, 1991-2010.
    Gozali AE; Britt B; Shane L; Gonzalez I; Gilles F; McComb JG; Krieger MD; Lavey RS; Shlien A; Villablanca JG; Erdreich-Epstein A; Dhall G; Jubran R; Tabori U; Malkin D; Finlay JL
    Pediatr Blood Cancer; 2012 Jun; 58(6):905-9. PubMed ID: 21990040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rare germline variant (rs78378222) in the TP53 3' UTR: Evidence for a new mechanism of cancer predisposition in Li-Fraumeni syndrome.
    Macedo GS; Araujo Vieira I; Brandalize AP; Giacomazzi J; Inez Palmero E; Volc S; Rodrigues Paixão-Côrtes V; Caleffi M; Silva Alves M; Achatz MI; Hainaut P; Ashton-Prolla P
    Cancer Genet; 2016 Mar; 209(3):97-106. PubMed ID: 26823150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contribution of de novo and mosaic
    Renaux-Petel M; Charbonnier F; Théry JC; Fermey P; Lienard G; Bou J; Coutant S; Vezain M; Kasper E; Fourneaux S; Manase S; Blanluet M; Leheup B; Mansuy L; Champigneulle J; Chappé C; Longy M; Sévenet N; Paillerets BB; Guerrini-Rousseau L; Brugières L; Caron O; Sabourin JC; Tournier I; Baert-Desurmont S; Frébourg T; Bougeard G
    J Med Genet; 2018 Mar; 55(3):173-180. PubMed ID: 29070607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detailed haplotype analysis at the TP53 locus in p.R337H mutation carriers in the population of Southern Brazil: evidence for a founder effect.
    Garritano S; Gemignani F; Palmero EI; Olivier M; Martel-Planche G; Le Calvez-Kelm F; Brugiéres L; Vargas FR; Brentani RR; Ashton-Prolla P; Landi S; Tavtigian SV; Hainaut P; Achatz MI
    Hum Mutat; 2010 Feb; 31(2):143-50. PubMed ID: 19877175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Penetrance of adrenocortical tumours associated with the germline TP53 R337H mutation.
    Figueiredo BC; Sandrini R; Zambetti GP; Pereira RM; Cheng C; Liu W; Lacerda L; Pianovski MA; Michalkiewicz E; Jenkins J; Rodriguez-Galindo C; Mastellaro MJ; Vianna S; Watanabe F; Sandrini F; Arram SB; Boffetta P; Ribeiro RC
    J Med Genet; 2006 Jan; 43(1):91-6. PubMed ID: 16033918
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of the TP53 p.R337H mutation in breast cancer patients in Brazil.
    Giacomazzi J; Graudenz MS; Osorio CA; Koehler-Santos P; Palmero EI; Zagonel-Oliveira M; Michelli RA; Scapulatempo Neto C; Fernandes GC; Achatz MI; Martel-Planche G; Soares FA; Caleffi M; Goldim JR; Hainaut P; Camey SA; Ashton-Prolla P
    PLoS One; 2014; 9(6):e99893. PubMed ID: 24936644
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Childhood adrenocortical carcinoma as a sentinel cancer for detecting families with germline TP53 mutations.
    Choong SS; Latiff ZA; Mohamed M; Lim LL; Chen KS; Vengidasan L; Razali H; Abdul Rahman EJ; Ariffin H;
    Clin Genet; 2012 Dec; 82(6):564-8. PubMed ID: 22233476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Next generation sequencing is informing phenotype: a TP53 example.
    O'Shea R; Clarke R; Berkley E; Giffney C; Farrell M; O'Donovan E; Gallagher DJ
    Fam Cancer; 2018 Jan; 17(1):123-128. PubMed ID: 28509937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TP53 alterations determine clinical subgroups and survival of patients with choroid plexus tumors.
    Tabori U; Shlien A; Baskin B; Levitt S; Ray P; Alon N; Hawkins C; Bouffet E; Pienkowska M; Lafay-Cousin L; Gozali A; Zhukova N; Shane L; Gonzalez I; Finlay J; Malkin D
    J Clin Oncol; 2010 Apr; 28(12):1995-2001. PubMed ID: 20308654
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early detection of adrenocortical carcinoma in a child with Li-Fraumeni syndrome.
    Lin MT; Shieh JJ; Chang JH; Chang SW; Chen TC; Hsu WH
    Pediatr Blood Cancer; 2009 Apr; 52(4):541-4. PubMed ID: 19101993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic counseling can influence the course of a suspected familial cancer syndrome patient: from a case of Li-Fraumeni like syndrome with a germline mutation in the TP53 gene.
    Hwang SM; Lee ES; Shin SH; Kong SY
    Korean J Lab Med; 2008 Dec; 28(6):493-7. PubMed ID: 19127115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The profile and contribution of rare germline copy number variants to cancer risk in Li-Fraumeni patients negative for TP53 mutations.
    Silva AG; Krepischi AC; Pearson PL; Hainaut P; Rosenberg C; Achatz MI
    Orphanet J Rare Dis; 2014 Apr; 9():63. PubMed ID: 24775443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of germline or somatic TP53 missense mutation with oncogene amplification in tumors developed in patients with Li-Fraumeni or Li-Fraumeni-like syndrome.
    Sugawara W; Arai Y; Kasai F; Fujiwara Y; Haruta M; Hosaka R; Nishida K; Kurosumi M; Kobayashi Y; Akagi K; Kaneko Y
    Genes Chromosomes Cancer; 2011 Jul; 50(7):535-45. PubMed ID: 21484931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TP53 p.R337H prevalence in a series of Brazilian hereditary breast cancer families.
    Cury NM; Ferraz VE; Silva WA
    Hered Cancer Clin Pract; 2014 Mar; 12(1):8. PubMed ID: 24625245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p53 mutants G245S and R337H associated with the Li-Fraumeni syndrome regulate distinct metabolic pathways.
    Meneghetti BV; Wilson R; Dias CK; Cadore NA; Klamt F; Zaha A; Ferreira HB; Monteiro KM
    Biochimie; 2022 Jul; 198():141-154. PubMed ID: 35367578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of germline TP53 mutations in a prospective series of unselected patients with adrenocortical carcinoma.
    Raymond VM; Else T; Everett JN; Long JM; Gruber SB; Hammer GD
    J Clin Endocrinol Metab; 2013 Jan; 98(1):E119-25. PubMed ID: 23175693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The TP53 gene promoter is not methylated in families suggestive of Li-Fraumeni syndrome with no germline TP53 mutations.
    Finkova A; Vazna A; Hrachovina O; Bendova S; Prochazkova K; Sedlacek Z
    Cancer Genet Cytogenet; 2009 Aug; 193(1):63-6. PubMed ID: 19602465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The TP53 mutational spectrum and frequency of CHEK2*1100delC in Li-Fraumeni-like kindreds.
    Siddiqui R; Onel K; Facio F; Nafa K; Diaz LR; Kauff N; Huang H; Robson M; Ellis N; Offit K
    Fam Cancer; 2005; 4(2):177-81. PubMed ID: 15951970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and functional consequence of TP53 mutations in pediatric adrenocortical carcinoma: a children's oncology group study.
    Wasserman JD; Novokmet A; Eichler-Jonsson C; Ribeiro RC; Rodriguez-Galindo C; Zambetti GP; Malkin D
    J Clin Oncol; 2015 Feb; 33(6):602-9. PubMed ID: 25584008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiotherapy-induced malignancies in breast cancer patients with TP53 pathogenic germline variants (Li-Fraumeni syndrome).
    Petry V; Bonadio RC; Cagnacci AQC; Senna LAL; Campos RDNG; Cotti GC; Hoff PM; Fragoso MCBV; Estevez-Diz MDP
    Fam Cancer; 2020 Jan; 19(1):47-53. PubMed ID: 31748977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 63.